Christine Brown

About the Author Christine Brown


B.Riley FBR Thinks Medicinova’s Stock is Going to Recover

B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Medicinova (MNOV) yesterday and set a price target of $11.

Aeglea Biotherapeutics (AGLE) Receives a Buy from Needham

In a report released today, Chad Messer from Needham reiterated a Buy rating on Aeglea Biotherapeutics (AGLE), with a price target of $14.00.

Credit Suisse Thinks PBF Energy’s Stock is Going to Recover

Credit Suisse analyst Manav Gupta maintained a Buy rating on PBF Energy (PBF) yesterday and set a price target of $15.00.

Analyst Rating Update on This Canadian Energy Company

Citigroup analyst Scott Gruber maintained a Sell rating on Nine Energy Service (NINE) today and set a price target of $0.50.

Landstar System (LSTR) Gets a Sell Rating from Morgan Stanley

In a report released today, Ravi Shanker from Morgan Stanley maintained a Sell rating on Landstar System (LSTR), with a price target of …

Morgan Stanley Keeps a Hold Rating on JB Hunt (JBHT)

In a report released today, Ravi Shanker from Morgan Stanley maintained a Hold rating on JB Hunt (JBHT), with a price target of …

Morgan Stanley Maintains Their Sell Rating on Norfolk Southern (NSC)

In a report released today, Ravi Shanker from Morgan Stanley maintained a Sell rating on Norfolk Southern (NSC), with a price target of …

Hologic (HOLX) Receives a Hold from Leerink Partners

In a report released today, Richard Newitter from Leerink Partners maintained a Hold rating on Hologic (HOLX), with a price target of $41.00.

Novavax (NVAX) Received its Third Buy in a Row

After Ladenburg Thalmann & Co. and Cantor Fitzgerald gave Novavax (NASDAQ: NVAX) a Buy rating last month, the company received another Buy, this …

Needham Keeps Their Buy Rating on Trulieve Cannabis (TCNNF)

The company’s shares closed last Tuesday at $9.85.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts